diabetes
Conditions
Interventions
Control group:Placebo
Sponsors
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Aged between 18-70 years (including 18 years old and 70 years old); (2) T2DM patients who meet the diagnostic criteria; (3) Simple oral hypoglycemic drugs; (4) Blood glucose control is relatively stable for at least 3 months, and HbA1c is less than 9.0%; (5) Body mass index is between 24-28; (6) Able to understand the procedures and methods of this clinical study.
Exclusion criteria
Exclusion criteria: (1) Those who are using DPP-4 inhibitors or have used them in the past month; (2) Those who are using GLP-1, GLP-1 analogues or who have used them in the past month; (3) Those who are using Chinese medicine for treatment or have used Chinese medicine (including proprietary Chinese medicine) for treatment in the past month; (4) Use oral hypoglycemic drugs to treat those who do not meet the standard of blood sugar control and need to use insulin injections; (5) Combined serious diseases: heart failure, chronic liver and kidney diseases (inflammation, infection, abnormal metabolism); (6) Pregnant or lactating women.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glycated hemoglobin;Fasting blood glucose;Blood glucose 2 hours after meal; | — |
Secondary
| Measure | Time frame |
|---|---|
| TC;TG;HDL;LDL;HJMA-IR;TCM Syndrome Points; | — |
Countries
China
Contacts
Public ContactYao Zheng
Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Outcome results
None listed